Who
Nathan G. Brower
EVP, General Counsel
Company insider
Files Form 4 as: EVP, General Counsel, Nature's Sunshine Products.
In numbers
- Trades disclosed
- 69
- Buys
- 0
- Sells
- 7
- Bought
- $0
- Sold
- $1.0M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 4 Dec 2017
- Last trade
- 21 May 2026
- Last filed
- 22 May 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 21 May 2026filed 22 May 2026 | NATR Nature's Sunshine ProductsBiotechnology | SEC FORM 4 Sold | $262K12,015 at $21.84 | filing |
| 21 May 2026filed 22 May 2026 | NATR Nature's Sunshine ProductsBiotechnology | SEC FORM 4 Sold | $262K12,015 at $21.84 | filing |
| 15 May 2026filed 19 May 2026 | NATR Nature's Sunshine ProductsBiotechnology | SEC FORM 4 Code A | —9,001 at $0.00 | filing |
| 15 May 2026filed 19 May 2026 | NATR Nature's Sunshine ProductsBiotechnology | SEC FORM 4 Code A | —9,001 at $0.00 | filing |
| 5 May 2026filed 7 May 2026 | NATR Nature's Sunshine ProductsBiotechnology | SEC FORM 4 Code M | —2,014 at $0.00 | filing |
| 5 May 2026filed 7 May 2026 | NATR Nature's Sunshine ProductsBiotechnology | SEC FORM 4 Code F | $15K582 at $25.92 | filing |
| 5 May 2026filed 7 May 2026 | NATR Nature's Sunshine ProductsBiotechnology | SEC FORM 4 Code M | —2,235 at $0.00 | filing |
| 5 May 2026filed 7 May 2026 | NATR Nature's Sunshine ProductsBiotechnology | SEC FORM 4 Code F | $17K645 at $25.92 | filing |
| 5 May 2026filed 7 May 2026 | NATR Nature's Sunshine ProductsBiotechnology | SEC FORM 4 Code M | —1,526 at $0.00 | filing |
| 5 May 2026filed 7 May 2026 | NATR Nature's Sunshine ProductsBiotechnology | SEC FORM 4 Code F | $11K441 at $25.92 | filing |
| 5 May 2026filed 7 May 2026 | NATR Nature's Sunshine ProductsBiotechnology | SEC FORM 4 Code M | —2,014 at $0.00 | filing |
| 5 May 2026filed 7 May 2026 | NATR Nature's Sunshine ProductsBiotechnology | SEC FORM 4 Code F | $15K582 at $25.92 | filing |
| 5 May 2026filed 7 May 2026 | NATR Nature's Sunshine ProductsBiotechnology | SEC FORM 4 Code M | —2,235 at $0.00 | filing |
| 5 May 2026filed 7 May 2026 | NATR Nature's Sunshine ProductsBiotechnology | SEC FORM 4 Code F | $17K645 at $25.92 | filing |
| 5 May 2026filed 7 May 2026 | NATR Nature's Sunshine ProductsBiotechnology | SEC FORM 4 Code M | —1,526 at $0.00 | filing |
| 5 May 2026filed 7 May 2026 | NATR Nature's Sunshine ProductsBiotechnology | SEC FORM 4 Code F | $11K441 at $25.92 | filing |
| 20 Apr 2026filed 21 Apr 2026 | NATR Nature's Sunshine ProductsBiotechnology | SEC FORM 4 Code F | $35K1,289 at $27.07 | filing |
| 20 Apr 2026filed 21 Apr 2026 | NATR Nature's Sunshine ProductsBiotechnology | SEC FORM 4 Code F | $35K1,289 at $27.07 | filing |
| 11 Mar 2026filed 12 Mar 2026 | NATR Nature's Sunshine ProductsBiotechnology | SEC FORM 4 Code F | $24K953 at $24.76 | filing |
| 11 Mar 2026filed 12 Mar 2026 | NATR Nature's Sunshine ProductsBiotechnology | SEC FORM 4 Code F | $24K953 at $24.76 | filing |
News
Kenvue (NYSE:KVUE) and Nature's Sunshine Products (NASDAQ:NATR) Critical ComparisonNATR · tickerreport.com · 12 Oct 2026
0 headlines in the last 90 days name Nathan G. Brower; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.